Am J Transplant, Volume 20, Suppl 3 Archives - Page 79 of 223 - ATC Abstracts

2020 American Transplant Congress
Association between Pre-Transplant Frailty and Increased Length of Stay after Lung Transplantation
J. Schaenman, N. Ventigan, J. Huang, S. Jaladanki, L. Shih, S. Gee, D. Sayah, S. S. Weigt, A. Ardehali, R. Biniwale, D. Goldwater
David Geffen School of Medicine at UCLA, Los Angeles, CA
*Purpose: Given the growing numbers of older lung transplant candidates, there has been increasing interest in using frailty assessment for risk stratification of transplant candidates.…
2020 American Transplant Congress
The Plasma DdcfDNA Level Associates with the Pathological Characteristics in Renal Allograft
R. Wang, J. Shen, J. Wu, J. Chen
Kidney Disease Center, First Affiliated Hospital of Zhejiang University, Hangzhou, China
*Purpose: Donor-derived cell-free DNA (ddcfDNA) is a promising biomarker for monitoring the allograft health status, however, its relationship with the pathological characteristics is still elusive.*Methods:…
2020 American Transplant Congress
Ifnar Signaling on Myeloid Cells Does Not Contribute to Costimulation Independent Transplant Rejection
J. Habib, D. Mathews, Y. Dong, A. Stephenson, A. Adams
Emory University, Atlanta, GA
*Purpose: Costimulation blockade (CoB) is a promising new strategy that provides a more targeted therapy with fewer side effects compared to traditional transplant immunosuppressants, leading…
2020 American Transplant Congress
Non-Human Primate B Cells Into Regulatory B Cells by Activation with CpG
K. Lee¹, C. Rickert¹, K. Deng¹, N. Feeney¹, N. Tanimine², Q. Fu¹, G. Huai¹, J. Lei¹, C. Leguern¹, J. Markmann¹
¹Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, ²Gastroenterological Transplantation Surgery, Hiroshima University, Hiroshima, Japan
*Purpose: We previously generated Toll like receptor (TLR)-activated B cells in rodent settings. These B cells can suppress T cell proliferation via in vitro mixed…
2020 American Transplant Congress
Influence of Microbial Communities on Transplantation
K. Janek¹, J. Fechner¹, K. Krautkramer², S. Sudakaran³, J. Denu⁴, J. Handelsman³, F. Rey⁵, E. Vivas⁵, J. Mezrich¹
¹Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, ²University of Wisconsin School of Medicine and Public Health, Madison, WI, ³Wisconsin Institute for Discovery, Madison, WI, ⁴Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI, ⁵Bacteriology, University of Wisconsin-Madison, Madison, WI
*Purpose: A diverse microbiome is important in the generation, maintenance, and function of the immune system. Specific bacterial communities may have a relationship with organ…
2020 American Transplant Congress
The Effect of Expanding Utilization of Living Donor Liver Transplantation tn the United States
K. N. Wanis¹, A. Sarvet¹, M. J. Stensrud¹, B. Al-Judaibi², K. Tomiyama³, R. Hernandez-Alejandro³
¹Epidemiology, Harvard School of Public Health, Boston, MA, ²Division of Transplantation, University of Rochester, Rochester, NY, ³Division of Transplantation/Hepatobiliary Surgery, Department of Surgery, University of Rochester, Rochester, NY
*Purpose: We estimated the effect that expansion of living donor liver transplantation (LDLT) would have on mortality for individuals added to the waitlist.*Methods: Using data…
2020 American Transplant Congress
Induction Therapy with Basiliximab versus Thymoglobulin in African-American Kidney Transplant Recipients in the Current Era of Immunosuppression
M. Zachariah¹, I. Mallawaarachchi², N. Meeks³, D. Wright¹, R. Minawala¹, V. Liu¹, J. Rolls⁴, S. Hussein⁴, C. Jarrin⁵
¹Wayne State University, Detroit, MI, ²Division of Biostatistics, University of Virginia, Charlottsville, VA, ³Wayne State University School of Medicine, Detroit, MI, ⁴Surgery, Detroit Medical Center, Detroit, MI, ⁵Infectious Disease, Wayne State University, Detroit, MI
*Purpose: It is now common practice in the transplant community to select induction therapy on the basis of perceived immunological risk for acute rejection which…
2020 American Transplant Congress
Safety of A2 Incompatible Kidney Transplantation in Donors with Acute Kidney Injury
Y. Al Azzi, L. Liriano-Ward, G. Nair, M. Ajaimy, J. Graham, C. Pynadath, P. Nandigam, A. Colovai, A. Campbell, S. Greenstein, M. Kinkhabwala, J. Rocca, E. Akalin
Abdominal Transplant, Montefiore Medical Center, New York, NY
*Purpose: Kidneys with donor acute kidney injury (AKI) are frequently discarded. We aimed to study the outcomes of A2 incompatible kidney transplantation from donors with…
2020 American Transplant Congress
Calcium Oxalate Deposition in Kidney Allografts: Clinical Chracteristics and Outcome
S. Sritharan¹, J. Kamal², S. A. Husain¹, I. Batal¹, J. Chang¹
¹Columbia University Irving Medical Center, New York, NY, ²University of Virginia, Charlottesville, VA
*Purpose: To better understand its clinical significance and prognostic value, we investigated the clinical characteristics and outcomes of patients with calcium oxalate deposition in kidney…
2020 American Transplant Congress
Graft and Patient Survival after A2-Incompatible Living Donor Kidney Transplantation
S. Getsin, P. Chiang, S. Yu, K. Jackson, D. Segev, A. Massie
Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: ABO type B and O recipients have increased difficulty identifying a compatible donor for living-donor kidney transplantation (LDKT), and are harder to match in…